This metabolite incorporates a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 about 50% in the parent drug. Plasma concentrations of this metabolite are about 40% of People observed for sildenafil, so that the metabolite accounts for around 20% of sildenafil's pharmacologic effects.Hvis de lavere dosene ikke har fung